Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Boehringer’s Innovation Strategy Does Not Avoid Areas With Heavy Competition
Sep 04 2023
•
By
Joseph Haas
BI's R&D strategy centers on novel targets and breakthrough therapies for unmet needs • Source: Boehringer Ingelheim
(dieth+schröder-fotografie)
More from Strategy
More from Business